Stress ulcer prophylaxis versus placebo—a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD)

BACKGROUND: Critically ill infants with congenital heart disease (CHD) are often prescribed stress ulcer prophylaxis (SUP) to prevent upper gastrointestinal bleeding, despite the low incidence of stress ulcers and limited data on the safety and efficacy of SUP in infants. Recently, SUP has been asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Kimberly I., Albert, Ben D., Bechard, Lori J., Duggan, Christopher P., Kaza, Aditya, Rakoff-Nahoum, Seth, Vlamakis, Hera, Sleeper, Lynn A., Newburger, Jane W., Priebe, Gregory P., Mehta, Nilesh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322718/
https://www.ncbi.nlm.nih.gov/pubmed/32600393
http://dx.doi.org/10.1186/s13063-020-04513-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322718/
https://www.ncbi.nlm.nih.gov/pubmed/32600393
http://dx.doi.org/10.1186/s13063-020-04513-w

Ejemplares similares